Ferumoxytol: A new, clinically applicable label for stem-cell tracking in arthritic joints with MRI

Nanomedicine

Volumn 8, Issue 12, 2013, Pages 1969-1983

  Khurana, Aman ^a   Nejadnik, Hossein ^a   Chapelin, Fanny ^a   Lenkov, Olga ^a   Gawande, Rakhee ^a   Lee, Sungmin ^b   Gupta, Sandeep N ^c   Aflakian, Nooshin ^a   Derugin, Nikita ^a   Messing, Solomon ^a   Lin, Guiting ^d   Lue, Tom F ^d   Pisani, Laura ^a   Daldrup Link, Heike E ^a  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

^c GE GLOBAL RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

iron oxide nanoparticle; matrix associated stem cell implant; MRI; osteoarthritis; stem cell tracking

Indexed keywords

FERUMOXYTOL; NANOPARTICLE; PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE DEFECT; CELL DIFFERENTIATION; CELL LABELING; CELL VIABILITY; CHONDROGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMUR; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; IRON TRANSPORT; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; SIGNAL NOISE RATIO; STEM CELL TRANSPLANTATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ARTHRITIS; CELL TRACKING; CELLS, CULTURED; CONTRAST MEDIA; FEMALE; FEMUR; FERROSOFERRIC OXIDE; JOINTS; MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION SOLUTIONS; RATS; RATS, NUDE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84884695107     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.198     Document Type: Article

References (65)

1. Centers for Disease Control and Prevention. Prevalence of doctor-diagnosed arthritis and arthritis-Attributable activity limitation-United States, 2007-2009. MMWR Morb. Mortal. Wkly Rep. 59(39), 1261-1265 (2010
2. Centers for Disease Control and Prevention. Arthritis. Meeting the Challenge at a Glance 2011. National Center for Chronic Disease Prevention and Health Promotion, GA, USA (2011
3. Hunziker EB. Articular cartilage repair: Problems and perspectives. Biorheology 37(1-2), 163-164 (2000 (Pubitemid 30353545)
4. Kinner B, Capito RM, Spector M. Regeneration of articular cartilage. Adv. Biochem. Eng. Biotechnol. 94, 91-123 (2005 (Pubitemid 44608657)
5. Boddington SE, Sutton EJ, Henning TD et al. Labeling human mesenchymal stem cells with fluorescent contrast agents: The biological impact. Mol. Imaging Biol. 13(1), 3-9 (2011
6. Brittberg M. Autologous chondrocyte transplantation. Clin. Orthop. Relat. Res. (Suppl. 367), S147-S155 (1999 (Pubitemid 29501496)
7. Brittberg M, Tallheden T, Sjogren-Jansson B, Lindahl A, Peterson L. Autologous chondrocytes used for articular cartilage repair: An update. Clin. Orthop. Relat. Res. (Suppl. 391), S337-S348 (2001 (Pubitemid 32954037)
8. Galle J, Bader A, Hepp P et al. Mesenchymal stem cells in cartilage repair: State of the art and methods to monitor cell growth, differentiation and cartilage regeneration. Curr. Med. Chem. 17(21), 2274-2291 (2010
9. Gao J, Yao JQ, Caplan AI. Stem cells for tissue engineering of articular cartilage. Proc. Inst. Mech. Eng. H 221(5), 441-450 (2007 (Pubitemid 47303933)
10. Hunziker EB. Articular cartilage repair: Are the intrinsic biological constraints undermining this process insuperable? Osteoarthritis Cartilage 7(1), 15-28 (1999 (Pubitemid 29112957)
11. Molcanyi M, Riess P, Bentz K et al. Trauma associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain. J. Neurotrauma 24(4), 625-637 (2007 (Pubitemid 46996023)
12. Li P, Tessler A, Han SS, Fischer I, Rao MS, Selzer ME. Fate of immortalized human neuronal progenitor cells transplanted in rat spinal cord. Arch. Neurol. 62(2), 223-229 (2005 (Pubitemid 40204743)
13. Bredella MA, Tirman PF, Peterfy CG et al. Accuracy of T2-weighted fast spin-echo MR imaging with fat saturation in detecting cartilage defects in the knee: Comparison with arthroscopy in 130 patients. AJR Am. J. Roentgenol. 172(4), 1073-1080 (1999 (Pubitemid 29505643)
14. Eckstein F, Reiser M, Englmeier KH, Putz R. In vivo morphometry and functional analysis of human articular cartilage with quantitative magnetic resonance imaging-from image to data, from data to theory. Anat. Embryol. (Berl.) 203(3), 147-173 (2001) (Pubitemid 32186473)
15. Nedopil A, Klenk C, Kim C et al. MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-Associated stem cell implants for treatment of osteoarthritis. Invest. Radiol. 45(10), 634-640 (2010
16. Wang YX. In vivo magnetic resonance imaging of animal models of knee osteoarthritis. Lab. Anim. 42(3), 246-264 (2008
17. Henning TD, Boddington S, Daldrup-Link HE. Labeling hESCs and hMSCs with iron oxide nanoparticles for noninvasive in vivo tracking with MR imaging. J. Vis. Exp. (13), (2008
18. Henning TD, Sutton EJ, Kim A et al. The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. Contrast Media Mol. Imaging 4(4), 165-173 (2009
19. Nedopil AJ, Mandrussow LG, Daldrup-Link HE. Implantation of ferumoxides labeled human mesenchymal stem cells in cartilage defects. J. Vis. Exp. 38, 1793 (2010
20. Simon GH, Von Vopelius-Feldt J, Fu Y et al. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: A comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol. Invest. Radiol. 41(1), 45-51 (2006 (Pubitemid 44378278)
21. Sutton EJ, Henning TD, Boddington S et al. In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label. Mol. Imaging 9(5), 278-290 (2010
22. Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA. In vivo cellular imaging for translational medical research. Curr. Med. Imaging Rev. 5(1), 19-38 (2009
23. Bulte JW. In vivo MRI cell tracking: Clinical studies. AJR Am. J. Roentgenol. 193(2), 314-325 (2009
24. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3(4), 343-355 (2011
25. Coyne DW. Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease. Exp. Opin. Pharmacother. 10(15), 2563-2568 (2009
26. Peng L, Jia Z, Yin X et al. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage and adipose tissue. Stem Cells Dev. 17(4), 761-773 (2008
27. Huang JI, Zuk PA, Jones NF et al. Chondrogenic potential of multipotential cells from human adipose tissue. Plast. Reconstr. Surg. 113(2), 585-594 (2004 (Pubitemid 39201927)
28. Im GI, Shin YW, Lee KB Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 13(10), 845-853 (2005
29. Winter A, Breit S, Parsch D et al. Cartilage-like gene expression in differentiated human stem cell spheroids: A comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum. 48(2), 418-429 (2003 (Pubitemid 36278011)
30. Ning H, Lin G, Lue TF, Lin CS. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 74(9-10), 510-518 (2006
31. Strem BM, Hicok KC, Zhu M et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J. Med. 54(3), 132-141 (2005 (Pubitemid 41542713)
32. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12), 4279-4295 (2002 (Pubitemid 35471185)
33. Mitchell JB, Mcintosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-Associated and stem cell-Associated markers. Stem Cells 24(2), 376-385 (2006 (Pubitemid 44464807)
34. Neuwelt EA, Hamilton BE, Varallyay CG et al. Ultrasmall superparamagnetic iron oxides (USPIOs): A future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int. 75(5), 465-474 (2009
35. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11(11), 2319-2331 (2001 (Pubitemid 33041104)
36. Arbab AS, Yocum GT, Kalish H et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104(4), 1217-1223 (2004 (Pubitemid 39038047)
37. Arbab AS, Yocum GT, Rad AM et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18(8), 553-559 (2005 (Pubitemid 43013896)
38. Castaneda RT, Khurana A, Khan R, Daldrup-Link HE. Labeling stem cells with ferumoxytol, an FDA-Approved iron oxide nanoparticle. J. Vis. Exp. (57), e3482 (2011
39. Thu MS, Bryant LH, Coppola T et al. Self assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat. Med. 18(3), 463-467 (2012
40. Wolff SD, Balaban RS. Assessing contrast on MR images. Radiology 202(1), 25-29 (1997 (Pubitemid 27024102)
41. Dosa E, Guillaume DJ, Haluska M et al. Magnetic resonance imaging of intracranial tumors: Intra-patient comparison of gadoteridol and ferumoxytol. Neuro. Oncol. 13(2), 251-260 (2011
42. Harisinghani M, Ross RW, Guimaraes AR, Weissleder R. Utility of a new bolus-injectable nanoparticle for clinical cancer staging. Neoplasia 9(12), 1160-1165 (2007 (Pubitemid 350255363)
43. Li W, Tutton S, Vu AT et al. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J. Magn. Reson. Imaging 21(1), 46-52 (2005 (Pubitemid 40041419)
44. Neuwelt EA, Varallyay CG, Manninger S et al. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: A pilot study. Neurosurgery 60(4), 601-611; discussion 611-612 (2007
45. Ersoy H, Jacobs P, Kent CK, Prince MR. Blood pool MR angiography of aortic stent-graft endoleak. AJR Am. J. Roentgenol. 182(5), 1181-1186 (2004 (Pubitemid 38525510)
46. Gahramanov S, Raslan AM, Muldoon LL et al. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: A pilot study. Int. J. Radiat. Oncol. Biol. Phys. 79(2), 514-523 (2011
47. Farrell E, Wielopolski P, Pavljasevic P et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem. Biophys. Res. Commun. 369(4), 1076-1081 (2008
48. Henning TD, Gawande R, Khurana A et al. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: In vitro and in vivo investigations. Mol. Imaging 11(3), 197-209 (2011
49. Wang L, Deng J, Wang J et al. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Magn. Reson. Imaging 27(1), 108-119 (2009
50. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 104(10), 3410-3413 (2004 (Pubitemid 39507168)
51. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 17(7), 513-517 (2004 (Pubitemid 39549429)
52. Lu M, Cohen MH, Rieves D, Pazdur R. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am. J. Hematol. 85(5), 315-319 (2010
53. Daldrup-Link HE, Rudelius M, Oostendorp RA et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228(3), 760-767 (2003 (Pubitemid 37025487)
54. Babic M, Horak D, Trchova M et al. Poly(l-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug. Chem. 19(3), 740-750 (2008 (Pubitemid 351431406)
55. Xu Q, Zhang HT, Liu K et al. In vitro and in vivo magnetic resonance tracking of Sinerem-labeled human umbilical mesenchymal stromal cell-derived Schwann cells. Cell. Mol. Neurobiol. 31(3), 365-375 (2011
56. Wu YJ, Muldoon LL, Varallyay C, Markwardt S, Jones RE, Neuwelt EA. In vivo leukocyte labeling with intravenous ferumoxides/ protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Am. J. Physiol. Cell Physiol. 293(5), C1698-C1708 (2007 (Pubitemid 350085639)
57. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J. Rheumatol. 24(7), 1350-1354 (1997 (Pubitemid 27353380)
58. Brown CC, Balian G. Effect of heparin on synthesis of short chain collagen by chondrocytes and smooth muscle cells. J. Cell. Biol. 105(2), 1007-1012 (1987 (Pubitemid 18043861)
59. Cromer Berman SM, Kshitiz, Wang CJ et al. Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn. Reson. Med. 69(1), 255-262 (2012
60. Kraitchman DL, Heldman AW, Atalar E et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107(18), 2290-2293 (2003 (Pubitemid 36578497)
61. Vidal MA, Walker NJ, Napoli E, Borjesson DL. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Stem Cells Dev. 21(2), 273-283 (2011
62. Berman SC, Galpoththawela C, Gilad AA, Bulte JW, Walczak P. Long-Term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn. Reson. Med. 65(2), 564-574 (2011
63. Küstermann E, Himmelreich U, Kandal K et al. Efficient stem cell labeling for MRI studies. Contrast Media Mol. Imaging 3(1), 27-37 (2008 (Pubitemid 351493976)
64. Saborowski O, Simon GH, Raatschen HJ et al. MR imaging of antigen-induced arthritis with a new, folate receptor-Targeted contrast agent. Contrast Media Mol. Imaging 2(2), 72-81 (2007 (Pubitemid 46863623)
65. Anderson SA, Lee KK, Frank JA. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest. Radiol. 41(3), 332-338 (2006 (Pubitemid 44406195) Skin Diseases